Merus Labs International Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 18   

Articles published

MSLI 2.19 +0.07 (3.30%)
price chart
Merus Labs International Inc. Announces Conversion of $10 Million Convertible ...
In aggregate, the Company will issue 6,677,918 common shares to convert the outstanding $10 million principal amount plus accrued but unpaid interest.
Related articles »  
Merus Labs International Inc. Announces Closing of $10 Million Preferred Share ...
TORONTO, ONTARIO, Jul 11, 2014 (Marketwired via COMTEX) -- Merus Labs International Inc. ("Merus" or the "Company") (TOR:CA:MSL) (NASDAQ:MSLI) is pleased to announce today that the Company has completed its previously announced private ... Neither the ...
Related articles »  
Dacha mails information circular for annual and special meeting of shareholders
the previously announced transaction pursuant to which Merus Labs International Inc. ("Merus") (TSX: MSL, NASDAQ: MSLI) will acquire from Dacha, in exchange for common shares of Merus ("Merus Shares") priced at $1.70 per share, a new subsidiary to be ...
Related articles »  
Dacha releases audited financial statements for year ended March 31, 2014 and ...
... via COMTEX) -- Dacha Strategic Metals Inc. (CVE:CA:DSM) ("Dacha") today released its audited consolidated financial results for the year ended March 31, 2014 and provided an update on its pending transaction involving Merus Labs International Inc ...
Related articles »  
Investing in the Best Canadian Biotech Stocks
Investing Basics · International Investing .... ($CXR:CA), Cipher Pharmaceuticals Inc. ($DND:CA), Tribute Pharmaceuticals Canada Inc. ($TRX:CA) ($TBUFF) and Merus Labs Inc. ($MSL:CA). Those six and others are specialty pharmaceutical companies, smaller ...
Related articles »